Focus Stocks
Cognizant Technology Solutions Close to Resistance
Published on Wednesday, 08 February 2012 06:40 Written by TradersHuddle Wire
New York, February 8th (TradersHuddle.com) - Shares of Cognizant Technology Solutions Corporation (NASDAQ:CTSH) are trading very close to calculated resistance at $74.19 with the current price action closing at just $72.01 placing the stock near levels that make it difficult to buy.
Cognizant Technology Solutions Corporation (NASDAQ:CTSH) provides custom Information Technology (IT) consulting and technology services as well as outsourcing services. The Company focus in technology strategy consulting, complex systems development, and enterprise software package implementation.
Cognizant's current stock range is defined by current calculated support defined at $62.96 and by the resistance level at $74.19, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for Cognizant Technology Solutions, as the stock is well above support, however, as the stock pulls back towards $62.96 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $74.19 then traders will get an opportunity to enter Cognizant Technology Solutions stock by establishing a position as the stock moves to a higher range.
Related Articles
- Approaching Resistance: Cognizant Technology Solutions
- NASDAQ 100 Worst Performer: Perrigo
- Cognizant Technology Solutions - Above Average Volume Detected
- Is Cognizant Technology Solutions Oversold?
- NASDAQ 100's Top Performers: VRTX, NVDA, SHLD
- TradersHuddle Scanner - High Volume For Cognizant Technology Solutions
- Is Cognizant Technology Solutions Breaking Down?
- Is Cognizant Technology Solutions Expecting Resistance Soon?
- Approaching Support: Cognizant Technology Solutions
- Cognizant Technology Solutions Is Near Resistance
Related Partner Headlines
- Cognizant Technology Solutions Corporation (CTSH): Today's Featured Computer Software & Services Winner - TheStreet.com
- UPDATE: Jefferies Reduces PT to $76 on Cognizant Technology Solutions - Benzinga
- Cognizant Technology Rises On Unusually High Volume (CTSH) - TheStreet.com
- Cognizant Technology: S&P Intraday Gainer - TheStreet.com
- UPDATE: Goldman Sachs Lowers Cognizant's PT - Benzinga
- UPDATE: J.P. Morgan Lowers Cognizant's PT - Benzinga
- Cognizant Technology Solutions Corporation (CTSH): Today's Featured Computer Software & Services Loser - TheStreet.com
- Cognizant Technology: S&P Intraday Laggard - TheStreet.com
- Yahoo! Cognizant, Sirius XM: Premarket Movers - TheStreet.com
- Cognizant Down 12% Pre-Market After Lowering Full Year Guidance - Benzinga
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









